Top compounds associated with response to CLDN34


Feature Type Standardized
Nominal ANOVA
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.018 0.6
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.015 0.6
mRNA BRD-K44224150 CTRPv2 pan-cancer AAC -0.038 0.6
mRNA FQI-2 CTRPv2 pan-cancer AAC 0.016 0.6
mRNA salermide CTRPv2 pan-cancer AAC 0.023 0.6
mRNA Mitomycin-C CTRPv2 pan-cancer AAC -0.016 0.6
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.019 0.6
mRNA LY-2157299 CTRPv2 pan-cancer AAC 0.036 0.6
mRNA WP1130 CTRPv2 pan-cancer AAC 0.017 0.6
mRNA Erlotinib CTRPv2 pan-cancer AAC 0.017 0.6
Download CSV